509 related articles for article (PubMed ID: 26401032)
1. Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.
Tekeste SS; Wilkinson TA; Weiner EM; Xu X; Miller JT; Le Grice SF; Clubb RT; Chow SA
J Virol; 2015 Dec; 89(23):12058-69. PubMed ID: 26401032
[TBL] [Abstract][Full Text] [Related]
2. Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase.
Wilkinson TA; Januszyk K; Phillips ML; Tekeste SS; Zhang M; Miller JT; Le Grice SF; Clubb RT; Chow SA
J Biol Chem; 2009 Mar; 284(12):7931-9. PubMed ID: 19150986
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.
Dobard CW; Briones MS; Chow SA
J Virol; 2007 Sep; 81(18):10037-46. PubMed ID: 17626089
[TBL] [Abstract][Full Text] [Related]
4. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.
Zhu K; Dobard C; Chow SA
J Virol; 2004 May; 78(10):5045-55. PubMed ID: 15113886
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.
Jayappa KD; Ao Z; Wang X; Mouland AJ; Shekhar S; Yang X; Yao X
J Virol; 2015 Apr; 89(7):3497-511. PubMed ID: 25568209
[TBL] [Abstract][Full Text] [Related]
6. AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription.
Lemay J; Maidou-Peindara P; Cancio R; Ennifar E; Coadou G; Maga G; Rain JC; Benarous R; Liu LX
J Mol Biol; 2008 Nov; 383(4):783-96. PubMed ID: 18786546
[TBL] [Abstract][Full Text] [Related]
7. Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) in Facilitating IN Assembly and Nonenzymatic Function through the IN Precursor Form with Reverse Transcriptase.
Takahata T; Takeda E; Tobiume M; Tokunaga K; Yokoyama M; Huang YL; Hasegawa A; Shioda T; Sato H; Kannagi M; Masuda T
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795445
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Uncoating and Reverse Transcription Require eEF1A Binding to Surface-Exposed Acidic Residues of the Reverse Transcriptase Thumb Domain.
Rawle DJ; Li D; Swedberg JE; Wang L; Soares DC; Harrich D
mBio; 2018 Mar; 9(2):. PubMed ID: 29588400
[TBL] [Abstract][Full Text] [Related]
9. Specific Interaction between eEF1A and HIV RT Is Critical for HIV-1 Reverse Transcription and a Potential Anti-HIV Target.
Li D; Wei T; Rawle DJ; Qin F; Wang R; Soares DC; Jin H; Sivakumaran H; Lin MH; Spann K; Abbott CM; Harrich D
PLoS Pathog; 2015 Dec; 11(12):e1005289. PubMed ID: 26624286
[TBL] [Abstract][Full Text] [Related]
10. A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication.
Herzig E; Voronin N; Kucherenko N; Hizi A
J Virol; 2015 Aug; 89(16):8119-29. PubMed ID: 25995261
[TBL] [Abstract][Full Text] [Related]
11. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication.
Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V
Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027
[TBL] [Abstract][Full Text] [Related]
12. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import.
Ao Z; Fowke KR; Cohen EA; Yao X
Retrovirology; 2005 Oct; 2():62. PubMed ID: 16232319
[TBL] [Abstract][Full Text] [Related]
14. Biochemical interactions between HIV-1 integrase and reverse transcriptase.
Chakraborty A; Sun GQ; Mustavich L; Huang SH; Li BL
FEBS Lett; 2013 Mar; 587(5):425-9. PubMed ID: 23270839
[TBL] [Abstract][Full Text] [Related]
15. Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
Ojwach DBA; Madlala P; Gordon M; Ndung'u T; Mann JK
Virology; 2021 Feb; 554():1-8. PubMed ID: 33316731
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other.
Tasara T; Maga G; Hottiger MO; Hübscher U
FEBS Lett; 2001 Oct; 507(1):39-44. PubMed ID: 11682056
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function.
Mandal D; Dash C; Le Grice SF; Prasad VR
Nucleic Acids Res; 2006; 34(10):2853-63. PubMed ID: 16723431
[TBL] [Abstract][Full Text] [Related]
19. Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutations.
Andreatta KN; Goodman DD; Miller MD; White KL
Antimicrob Agents Chemother; 2015; 59(6):3441-9. PubMed ID: 25824231
[TBL] [Abstract][Full Text] [Related]
20. Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
Rawle DJ; Li D; Wu Z; Wang L; Choong M; Lor M; Reid RC; Fairlie DP; Harris J; Tachedjian G; Poulsen SA; Harrich D
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
